Hydrophobic interactions of phenoxazine modulators with bovine serum albumin
Tóm tắt
The interaction of 10-(3′-N-morpholinopropyl)phenoxazine [MPP], 10-(4′-N-morpholinobutyl)phenoxazine [MBP], 10-(3′-N-morpholinopropyl)-2-chlorophenoxazine [MPCP], 10-(3′-N-piperidinopropyl)-2-chlorophenoxazine [PPCP] or 10-(3′-N-morpholinopropyl)-2-trifluoromethylphenoxazine [MPTP] with bovine serum albumin (BSA) has been studied by gel filtration and equilibrium dialysis methods. The binding of these modulators, based on dialysis experiments, has been characterized using the following parameters: percentage of bound drug (Β), the association constant (K
1), the apparent binding constant (k) and the free energy change (δF‡). The binding of phenoxazine derivatives to serum transporter protein, BSA, is correlated with their octanol-water partition coefficient, log10
P. In addition, effect of the displacing activities of hydroxyzine and acetylsalicylic acid on the binding of phenoxazine derivatives to albumin has been studied. Results of the displacement experiments show that phenoxazine benzene rings and tertiary amines attached to the side chain of the phenoxazine moiety are bound to a hydrophobic area on the albumin molecule.
Tài liệu tham khảo
Krieglstein J, Meiler W and Staab J 1972Biochem. Pharmacol. 21 985
Hulshoff A and Perrin J H 1977J. Med. Chem. 20 430
Glasser H and Krieglstein J 1970Naunyn-Schmiedebergs Arch. Pharmakol. 265 331
Thimmaiah K N, Horton J K, Seshadri R, Israel M, Houghton J A, Harwood F C and Houghton P J 1992J. Med. Chem. 35 3358
Thimmaiah K N, Horton J K, Qian X D, Beck W T, Houghton J A and Houghton P J 1990Cancer Commun. 2 249
Horton J K, Thimmaiah K N, Harwood F C, Kuttesh J D and Houghton P J 1993Mol. Pharmacol. 44 552
Thimmaiah K N, Jayashree B S, Germain G S, Houghton P J and Horton J K 1998Oncol. Res. 10 29
Eregowda G B, Kalpana H N, Hegde R and Thimmaiah K NIndian J. Chem. B (in press).
Eregowda G B, Krishnegowda G, Kalpana H N, Channu B C, Dass C, Horton J K, Houghton P J and Thimmaiah K N 1999Asian J. Chem. 11 878
Zamora J M, Pearce H L and Beck W T 1988Mol. Pharmacol. 33 454
Bird A E and Marshall A C 1967Biochem. Pharmacol. 16 2275
Hansch C 1968J. Med. Chem. 11 920
Hansch C and Fujita T 1964J. Am. Chem. Soc. 86 1616
Hansch C, Kiehs K and Lawrence G L 1965J. Am. Chem. Soc. 87 5770
Scholtan W, Schlossmann K and Rosenkranz H 1968Arzneimitted-Forsch. 18 767
Kauzmann W 1959Adv. Protein Chem. 141
Girard A 1962US Patent 3 048, 586; 1963Chem. Abstr. 58 147lg
Franz J W, Jahnchen E and Krieglstein J 1969Naunyn-Schmiedebergs Arch. Pharmakol. 264 462